Indicators

Markets:

News

Latest News about ALNY

Recent news which mentions ALNY

...

4 5 6 7 8 9 10 11 Next >

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

April 24, 2022

7 Potential Biotech Stocks Buyout Targets in 2022

April 21, 2022

Alnylam Pharmaceuticals Q1 2022 Earnings Conference Call On April 28, 2022 At 08:30 AM ET

April 19, 2022

Analyst Ratings for Alnylam Pharmaceuticals

April 12, 2022

7 Biotech Stocks to Buy With Key Catalysts for April

April 05, 2022

See Why Did FDA Extend Review Period For Alnylam's Vutrisiran In Amyloidosis

April 04, 2022

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

April 01, 2022

3 Healthcare Stocks That Could Rise 28% or More, According to Wall Street

March 21, 2022

Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters

March 18, 2022

Alnylam Hits Pfizer, Moderna With Patent Infringement Suits

March 17, 2022

What 8 Analyst Ratings Have To Say About Alnylam Pharmaceuticals

March 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022

March 01, 2022

Looking Into Alnylam Pharmaceuticals's Return On Capital Employed

February 11, 2022

Expert Ratings For Alnylam Pharmaceuticals

February 11, 2022

Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B

February 10, 2022

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

February 10, 2022

Alnylam Pharmaceuticals: Q4 Earnings Insights

February 10, 2022

Earnings Scheduled For February 10, 2022

February 10, 2022

12 biotech stocks to consider buying now as prospects for the sector brighten this year

February 06, 2022

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022

February 03, 2022

A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart

January 21, 2022

Alnylam' Reveals Detailed 18-Month Data From Vutrisiran Trial In Inherited Disease

January 21, 2022

The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective

January 21, 2022

What 10 Analyst Ratings Have To Say About Alnylam Pharmaceuticals

January 20, 2022

The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week

January 16, 2022

3 Can't-Miss Biotech Events Coming Up in 2022

January 07, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022

January 03, 2022

What 9 Analyst Ratings Have To Say About Alnylam Pharmaceuticals

January 03, 2022

Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates

December 31, 2021

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.